Skip to main content

Table 1 Clinical Characteristics of Patients Before and After Propensity Score Matching

From: Impact of time in range during hospitalization on clinical outcomes in diabetic patients with toe amputation: a propensity score matching analysis

Characteristic

Before propensity score matching

After propensity score matching

TIR < 70 (n = 224)

TIR ≥ 70 (n = 234)

P-value

TIR < 70 (n = 191)

TIR ≥ 70 (n = 191)

P-value

Age, median (IQR), years

67.0 (60.0–74.0)

67.0 (61.0–73.8)

0.937

67.0 (60.0–74.0)

67.0 (59.5–72.5)

0.670

Sex, n (%)

 Male

148 (66.1%)

157 (67.1%)

0.817

132 (69.1%)

130 (68.1%)

0.826

 Female

76 (33.9%)

77 (32.9%)

59 (30.9%)

61 (31.9%)

BMI, median (IQR), kg/m2

23.0 (20.9–25.0)

22.9 (21.3–25.4)

0.707

23.0 (21.0–25.0)

22.9 (21.3–25.4)

0.971

Preoperative blood glucose, n (%)

 < 6.1

35 (15.6%)

80 (34.2%)

 < 0.001

35 (18.3%)

47 (24.6%)

0.135

 ≥ 6.1

189 (84.4%)

154 (65.8%)

156 (81.7%)

144 (75.4%)

Preoperative HbA1c, n (%)

 < 7.5

46 (20.5%)

62 (26.5%)

0.133

43 (22.5%)

43 (22.5%)

1.000

 ≥ 7.5

178 (79.5%)

172 (73.5%)

148 (77.5%)

148 (77.5%)

Preoperative WBC, median (IQR)

9.5 (7.1–12.6)

8.4 (6.5–11.6)

0.004

9.3 (7.0–12.2)

8.6 (6.7–11.8)

0.164

Preoperative neutrophil, median (IQR)

6.9 (5.1–10.2)

5.9 (4.2–8.8)

0.004

6.6 (4.9–9.8)

6.1 (4.4–9.0)

0.215

Preoperative lymphocyte, median (IQR)

1.5 (1.1–1.8)

1.5 (1.1–1.9)

0.420

1.4 (1.1–1.8)

1.5 (1.1–1.8)

0.769

Preoperative platelet, median (IQR)

267.0 (215.0–354.2)

273.5 (214.2–344.8)

0.961

268.0 (215.0–355.0)

279.0 (218.0–346.5)

0.916

Preoperative CRP, n (%)

 < 8

43 (19.2%)

57 (24.4%)

0.181

38 (19.9%)

46 (24.1%)

0.323

 ≥ 8

181 (80.8%)

177 (75.6%)

153 (80.1%)

145 (75.9%)

Anemia, n (%)

 No

87 (38.8%)

96 (41.0%)

0.633

78 (40.8%)

78 (40.8%)

1.000

 Yes

137 (61.2%)

138 (59.0%)

113 (59.2%)

113 (59.2%)

Preoperative albumin, median (IQR)

31.6 (28.1–35.1)

33.1 (29.4–36.6)

0.006

32.2 (28.8–35.5)

32.6 (28.7–35.4)

0.922

Preoperative creatinine, median (IQR)

81.5 (60.8–108.2)

78.5 (59.0–108.0)

0.678

82.0 (60.0–110.5)

76.0 (59.0–105.0)

0.286

Smoking, n (%)

 No

165 (73.7%)

176 (75.2%)

0.703

140 (73.3%)

143 (74.9%)

0.726

 Yes

59 (26.3%)

58 (24.8%)

51 (26.7%)

48 (25.1%)

Drinking, n (%)

 No

171 (76.3%)

178 (76.1%)

0.946

144 (75.4%)

145 (75.9%)

0.905

 Yes

53 (23.7%)

56 (23.9%)

47 (24.6%)

46 (24.1%)

Hypertension, n (%)

 No

118 (52.7%)

93 (39.7%)

0.006

95 (49.7%)

86 (45.0%)

0.356

 Yes

106 (47.3%)

141 (60.3%)

96 (50.3%)

105 (55.0%)

Kidney disease, n (%)

 No

168 (75.0%)

155 (66.2%)

0.040

139 (72.8%)

136 (71.2%)

0.732

 Yes

56 (25.0%)

79 (33.8%)

52 (27.2%)

55 (28.8%)

LEAD, n (%)

 No

74 (33.0%)

73 (31.2%)

0.673

61 (31.9%)

67 (35.1%)

0.515

 Yes

150 (67.0%)

161 (68.8%)

130 (68.1%)

124 (64.9%)

Preoperative bacterial culture, n (%)

 Negative

83 (37.1%)

103 (44.0%)

0.129

72 (37.7%)

82 (42.9%)

0.297

 Positive

141 (62.9%)

131 (56.0%)

119 (62.3%)

109 (57.1%)

Wagner score, n (%)

 1–3

160 (71.4%)

173 (73.9%)

0.548

140 (73.3%)

144 (75.4%)

0.639

 4–5

64 (28.6%)

61 (26.1%)

51 (26.7%)

47 (24.6%)

Number of toes, n (%)

 1

163 (72.8%)

170 (72.6%)

0.977

137 (71.7%)

140 (73.3%)

0.731

 2–5

61 (27.2%)

64 (27.4%)

54 (28.3%)

51 (26.7%)

  1. BMI body mass index, CRP C-reactive protein, IQR interquartile range, LEAD lower extremity arterial disease, LOS length of stay, TIR time in range